Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Pediatr Crit Care Med ; 23(5): 399-404, 2022 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-35583619

RESUMEN

OBJECTIVES: To determine the prevalence and time course of thiamine deficiency (TD) in PICU patients. DESIGN: Multicenter, prospective, cohort study between May 2019 and November 2019. SETTING: Three university-based tertiary care, mixed medical-surgical PICUs in Ankara, Turkey. PATIENTS: PICU patients 1 month to 18 years old. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We studied 476 patients and grouped them by TD status on days 1 and 3 of the PICU admission. There might be a risk of unintended bias since we excluded 386 patients because of the absence of consent, inadequate blood samples, loss of identifier information, and recent vitamin supplementation. On day 1, TD was present in 53 of 476 patients (11.1%) and median (minimum-maximum) thiamine levels were 65.5 ng/mL (5-431 ng/mL). On day 3, TD was present in 27 of 199 patients (13.6%) with repeated measurement. The median (minimum-maximum) thiamine levels were 63 ng/mL (13-357 ng/mL). The time course of TD from day 1 to day 3 in these 199 patients was as follows. In 21 of 199 patients (10.6%) with TD on day 1, 11 of 21 (52%) continued to have TD on day 3 and the other 10 of 21 patients (48%) improved to no longer having TD. In 178 of 199 patients (89.4%) without TD on day 1, 16 of 178 (9%) went on to develop TD by day 3, and the other 162 of 178 (91%) continued to have normal thiamine status. CONCLUSIONS: In the PICU population in three centers in Turkey, the prevalence of TD in the sample of patients was 11.1%. In those TD patients who had serial studies, we also identified that by day 3 some continued to be TD, and some patients improved to normal thiamine status. Of concern, however, is the population who develop TD over the course of PICU stay.


Asunto(s)
Enfermedad Crítica , Deficiencia de Tiamina , Niño , Estudios de Cohortes , Humanos , Unidades de Cuidado Intensivo Pediátrico , Prevalencia , Estudios Prospectivos , Tiamina , Deficiencia de Tiamina/epidemiología , Turquía/epidemiología
2.
Pediatr Emerg Care ; 37(6): 308-311, 2021 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-30106865

RESUMEN

OBJECTIVE: Carbon monoxide (CO) is a gas, which is produced by incomplete combustion of hydrocarbon-containing substances, and causes significant tissue and organ damage in the common event of CO poisoning. This study aims to evaluate the demographic, clinical, and laboratory characteristics of patients diagnosed with CO poisoning in the emergency department and to determine the factors associated with severe course in the acute phase of poisoning. METHODS: A total of 331 patients diagnosed with CO poisoning in Hacettepe University Children's Hospital, Pediatric Emergency Unit, between January 2004 and March 2014 were included in the study. Their demographic characteristics, presenting complaints, physical examination findings, Glasgow Coma Scale scores, carboxyhemoglobin, leukocyte, hemoglobin, troponin T, pH and lactate levels, type of treatment (normobaric or hyperbaric oxygen), intensive care unit admissions, and outcome of poisoning were investigated. RESULTS: Ninety-three patients were given hyperbaric oxygen. Fifty-one patients were admitted to the pediatric intensive care unit, 18 patients have had a severe clinical course, and 6 patients have died. The risk factors associated with severe disease course were determined to be low Glasgow Coma Scale score, high leukocyte count, and high troponin T levels at presentation. CONCLUSIONS: Glasgow Coma Scale score, leukocyte count, and troponin T level may be beneficial in predicting clinical outcomes and tailoring therapy in children with CO poisoning.


Asunto(s)
Intoxicación por Monóxido de Carbono , Oxigenoterapia Hiperbárica , Intoxicación por Monóxido de Carbono/diagnóstico , Intoxicación por Monóxido de Carbono/epidemiología , Intoxicación por Monóxido de Carbono/terapia , Carboxihemoglobina/análisis , Niño , Escala de Coma de Glasgow , Humanos , Unidades de Cuidados Intensivos , Troponina T
3.
Eur J Pediatr ; 170(3): 397-400, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20924603

RESUMEN

Mercury has a number of unique and fascinating properties. It is present in the environment in several forms, both organic and inorganic. Each of these forms has somewhat unique properties that differentiate them from the other forms, but all are toxic to humans in one way or the others. Mercury has been proven to be a potential source of poisoning in children as a result of the inappropriate handling of a liquid mercury. The cases of metallic mercury vapor intoxication not associated with occupational exposure may occur in school science laboratories, from mercury dust and powders, from latex paint containing a mercury-based fungicide, and from normal wear or installation of dental amalgam fillings. Another source of toxic mercury exposure can be broken thermometers, barometers, or sphygmomanometers that may occur in the home, and children are often victims of environmental exposure. In this paper, we present three members of a family who were exposed to mercury brought home from school by a family member. Since the mercury exposure was not known, the initial presentation and clinical picture suggested a misdiagnosis, a contagious infectious disease, because the onset of symptoms occurred at different times in the same family members. A subsequent change to a diagnosis of mercury intoxication and chelation therapy with meso-2,3-dimercaptosuccinic acid was started.


Asunto(s)
Intoxicación por Mercurio/diagnóstico , Adolescente , Terapia por Quelación , Niño , Femenino , Humanos , Masculino , Intoxicación por Mercurio/tratamiento farmacológico , Hermanos
4.
Pediatr Transplant ; 12(5): 506-9, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18672481

RESUMEN

Hyperbaric oxygen therapy is a technology that involves oxygen treatment at supra-atmospheric pressures in high concentrations, generating increased levels of physically dissolved oxygen in blood plasma. This form of transported oxygen, compared with oxygen chemically bound to hemoglobin, is able to enter tissues with minimal or almost no blood flow. Experimental studies have suggested that hyperoxemia provided by hyperbaric oxygen may be beneficial in the treatment of reperfusion injury. Organs procured from brain-dead hyperbaric oxygen-treated donors may have less cellular injury from ischemia, reperfusion, and no-reflow phenomenon, thus yielding organs in an optimized state for transplantation. This current report consists of a gratifying experience about hyperbaric oxygen treatment playing a possible role on preservation of donor organs in vivo. In the siblings reported here, improved organ function prior to transplantation and the successful organ functioning after transplantation suggests the possible beneficial effect of hyperbaric oxygen treatment on the ischemic insult generated from brain death and repetitive cardiac arrests. Hyperbaric oxygen seems to be a promising candidate as a bridge to transplantation, keeping the donated organs viable until the harvesting procedure can take place for potential brain dead donors. This experience may lead to further investigations on hyperbaric oxygen's role in donor organ preservation.


Asunto(s)
Muerte Encefálica , Oxigenoterapia Hiperbárica , Preservación de Órganos/instrumentación , Preservación de Órganos/métodos , Trasplante de Órganos/métodos , Preservación Biológica , Animales , Niño , Femenino , Humanos , Isquemia , Masculino , Daño por Reperfusión , Donantes de Tejidos , Obtención de Tejidos y Órganos
5.
Turk J Pediatr ; 50(2): 171-5, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18664083

RESUMEN

Hypercalcemia is a well-recognized complication of neoplastic disorders. Herein, we report a hypercalcemic pediatric acute lymphoblastic leukemia case at presentation refractory to hydration, furosemide, pamidronate and calcitonin. Normal serum calcium levels were achieved with the initiation of chemotherapy protocol including vincristine, daunomycin and high-dose methylprednisolone. The impact of high-dose methylprednisolone in the correction of severe hypercalcemia in steroid-responsive tumors as an initial treatment approach or for cases refractory to other measures may be life-saving.


Asunto(s)
Hipercalcemia/tratamiento farmacológico , Hipercalcemia/etiología , Metilprednisolona/administración & dosificación , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaciones , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Preescolar , Humanos , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA